Styrylpyridinium Derivatives as New Potent Antifungal Drugs and Fluorescence Probes

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985823%3A_____%2F20%3A00532982" target="_blank" >RIV/67985823:_____/20:00532982 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.frontiersin.org/articles/10.3389/fmicb.2020.02077/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fmicb.2020.02077/full</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3389/fmicb.2020.02077" target="_blank" >10.3389/fmicb.2020.02077</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Styrylpyridinium Derivatives as New Potent Antifungal Drugs and Fluorescence Probes

Popis výsledku v původním jazyce

The incidence ofCandida glabratainfections increases every year due to its higher resistance to commonly used antifungal drugs. We characterized the antifungal mechanism of action of eight new styrylpyridinium derivatives, with various N-alkyl chains (-C6H13, -C8H17, -C10H21, -C12H25) and different substituents, onC. glabratastrains differing in their drug resistance due to the presence or absence of two major drug-efflux pumps. We found that the tested styrylpyridinium compounds affected the growth ofC. glabratacells in a compound- and strain-dependent manner, and apparently they were substrates ofCgCdr1 andCgCdr2 pumps. Further, we determined the impact of the tested compounds on plasma membrane integrity. The ability to cause damage to a plasma membrane depended on the compound, its concentration and the presence of efflux pumps, and corresponded well with the results of growth and survival tests. We also tested possible synergism with three types of known antifungal drugs. Though we did not observe any synergism with azole drugs, styrylpyridinium compounds5and6together with FK506 demonstrated excellent antifungal properties, whereas compounds2,3,5, and6exhibited a significant synergistic effect in combination with terbinafine. Based on our results, derivatives2and6turned out to be the most promising antifungal drugs. Moreover, compound6was not only able to effectively permeabilize the yeast plasma membrane, but also exhibited significant synergism with FK506 and terbinafine. Finally, we also characterized the spectroscopic properties of the tested styrylpyridinium compounds. We measured their absorption and fluorescence spectra, determined their localization in yeast cells and found that their fluorescence characteristics differ from the properties of current commercial vacuolar styrylpyridinium markers and allow multi-color staining. Compounds1,3,7, and8were able to accumulate in plasma and vacuolar membranes, and compounds2,5, and6stained the whole interior of dead cells. In summary, of the eight tested compounds, compound6is the most promising antifungal drug, compound8, due to its minimal toxicity, is the best candidate for a new vacuolar-membrane probe or new benchmark substrate ofC. glabrataCdr pumps, and derivative5for a new vital dye.

Název v anglickém jazyce

Styrylpyridinium Derivatives as New Potent Antifungal Drugs and Fluorescence Probes

Popis výsledku anglicky

The incidence ofCandida glabratainfections increases every year due to its higher resistance to commonly used antifungal drugs. We characterized the antifungal mechanism of action of eight new styrylpyridinium derivatives, with various N-alkyl chains (-C6H13, -C8H17, -C10H21, -C12H25) and different substituents, onC. glabratastrains differing in their drug resistance due to the presence or absence of two major drug-efflux pumps. We found that the tested styrylpyridinium compounds affected the growth ofC. glabratacells in a compound- and strain-dependent manner, and apparently they were substrates ofCgCdr1 andCgCdr2 pumps. Further, we determined the impact of the tested compounds on plasma membrane integrity. The ability to cause damage to a plasma membrane depended on the compound, its concentration and the presence of efflux pumps, and corresponded well with the results of growth and survival tests. We also tested possible synergism with three types of known antifungal drugs. Though we did not observe any synergism with azole drugs, styrylpyridinium compounds5and6together with FK506 demonstrated excellent antifungal properties, whereas compounds2,3,5, and6exhibited a significant synergistic effect in combination with terbinafine. Based on our results, derivatives2and6turned out to be the most promising antifungal drugs. Moreover, compound6was not only able to effectively permeabilize the yeast plasma membrane, but also exhibited significant synergism with FK506 and terbinafine. Finally, we also characterized the spectroscopic properties of the tested styrylpyridinium compounds. We measured their absorption and fluorescence spectra, determined their localization in yeast cells and found that their fluorescence characteristics differ from the properties of current commercial vacuolar styrylpyridinium markers and allow multi-color staining. Compounds1,3,7, and8were able to accumulate in plasma and vacuolar membranes, and compounds2,5, and6stained the whole interior of dead cells. In summary, of the eight tested compounds, compound6is the most promising antifungal drug, compound8, due to its minimal toxicity, is the best candidate for a new vacuolar-membrane probe or new benchmark substrate ofC. glabrataCdr pumps, and derivative5for a new vital dye.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

10606 - Microbiology

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Frontiers in Microbiology

ISSN

1664-302X

e-ISSN

—

Svazek periodika

11

Číslo periodika v rámci svazku

Aug 28

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

14

Strana od-do

2077

Kód UT WoS článku

000570564900001

EID výsledku v databázi Scopus

2-s2.0-85090791449